137 related articles for article (PubMed ID: 36960703)
1. Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes.
Bikas A; Wong K; Pappa T; Ahmadi S; Wakefield CB; Marqusee E; Xiang P; Altshuler B; Haase J; Barletta JA; Landa I; Alexander EK
Thyroid; 2023 Jun; 33(6):697-704. PubMed ID: 36960703
[No Abstract] [Full Text] [Related]
2. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract][Full Text] [Related]
3. Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
Poma AM; Viola D; Macerola E; Proietti A; Molinaro E; De Vietro D; Elisei R; Materazzi G; Miccoli P; Basolo F; Ugolini C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4109-e4117. PubMed ID: 34061965
[TBL] [Abstract][Full Text] [Related]
4. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of the three major variants of papillary thyroid carcinoma.
Xu J; Zhang Y; Liu J; Qiu S; Wang M
J Int Med Res; 2021 Feb; 49(2):300060520984618. PubMed ID: 33535844
[TBL] [Abstract][Full Text] [Related]
7. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
8. Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.
Beninato T; Scognamiglio T; Kleiman DA; Uccelli A; Vaca D; Fahey TJ; Zarnegar R
Surgery; 2013 Dec; 154(6):1331-6; discussion 1336. PubMed ID: 24238051
[TBL] [Abstract][Full Text] [Related]
9. Classic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features.
Oh WJ; Lee YS; Cho U; Bae JS; Lee S; Kim MH; Lim DJ; Park GS; Lee YS; Jung CK
Korean J Pathol; 2014 Jun; 48(3):201-8. PubMed ID: 25013418
[TBL] [Abstract][Full Text] [Related]
10. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
[TBL] [Abstract][Full Text] [Related]
11. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
12. Papillary and Medullary Thyroid Carcinomas Presenting as Collision Tumors: A Case Series of 21 Cases at a Tertiary Care Cancer Center.
Thomas A; Mittal N; Rane SU; Bal M; Patil A; Ankathi SK; Vaish R
Head Neck Pathol; 2021 Dec; 15(4):1137-1146. PubMed ID: 33840044
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
[TBL] [Abstract][Full Text] [Related]
15. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
[TBL] [Abstract][Full Text] [Related]
16. Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm.
Lee JS; Lee JS; Yun HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
J Clin Endocrinol Metab; 2023 May; 108(6):1370-1375. PubMed ID: 36546348
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
[TBL] [Abstract][Full Text] [Related]
18. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.
Kim K; Jung CK; Lim DJ; Bae JS; Kim JS
Gland Surg; 2022 Jan; 11(1):56-66. PubMed ID: 35242669
[TBL] [Abstract][Full Text] [Related]
20. A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?
Turchini J; Fuchs TL; Chou A; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
Endocr Pathol; 2023 Dec; 34(4):461-470. PubMed ID: 37864666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]